Immunodominant T-cell epitopes in the factor VIII C2 domain are located within an inhibitory antibody binding site

Thrombosis and Haemostasis
Kathleen P PrattDavid W Scott

Abstract

Formation of inhibitor antibodies to factor VIII (FVIII) is a major complication of FVIII replacement therapy for hemophilia A patients, and it occurs through a T-cell dependent process. The C2 domain of FVIII contains epitopes that are recognized by antibody inhibitors. We have examined regions of the C2 domain that form epitopes for T cells in mice congenitally deficient in FVIII. We obtained CD4(+)T cells from mice immunized by intravenous infusion of therapeutic doses of recombinant human FVIII (rFVIII), or by subcutaneous injections of rFVIII or recombinant human C2 domain in adjuvant. In all cases, the T cells recognized most strongly and consistently two overlapping peptides that spanned residues 2191 to 2220 of the C2 domain. Analysis of the crystal structure of human factor VIII C2 bound to a human monoclonal antibody, BO2C11, showed these residues also constitute part of a human alloimmune B-cell epitope (Spiegel et al., Blood 2001; 98: 13-19). This region includes one of the "hydrophobic spike" protrusions, consisting of M2199 and F2200, as well as the basic residues R2215 and R2220. These residues contribute to membrane binding and to association with von Willebrand factor (vWF). These findings suggest that a major ...Continue Reading

Citations

Feb 25, 2005·The Journal of Biological Chemistry·Vivek S PurohitSathyamangalam V Balasubramanian
Jun 27, 2006·The AAPS Journal·Vivek S Purohit, Sathyamangalam V Balasubramanian
Oct 3, 2007·The AAPS Journal·Razvan D MicleaSathy V Balu-Iyer
May 21, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jonathan SkupskyDavid W Scott
Jan 22, 2005·Current Opinion in Pediatrics·Marilyn Manco-Johnson
Aug 5, 2006·Current Opinion in Hematology·Jenny GoudemandThierry Calvez
Jun 12, 2010·Haemophilia : the Official Journal of the World Federation of Hemophilia·D W Scott
Jan 8, 2011·The Biochemical Journal·Valerie A NovakovicGary E Gilbert
Aug 15, 2020·Frontiers in Immunology·Sylvain MeunierBernard Maillère
Aug 17, 2005·Journal of Thrombosis and Haemostasis : JTH·L AutinB O Villoutreix
Nov 13, 2012·Journal of Thrombosis and Haemostasis : JTH·A WroblewskaJ Voorberg
Jan 31, 2020·Frontiers in Immunology·Sebastien Lacroix-DesmazesKathleen P Pratt
Jul 11, 2006·Journal of Thrombosis and Haemostasis : JTH·F E RawleD Lillicrap
Feb 3, 2009·Clinical Reviews in Allergy & Immunology·Kathleen P Pratt, Arthur R Thompson
Feb 6, 2020·Frontiers in Immunology·David W Scott, Kathleen P Pratt
Dec 24, 2005·Journal of Pharmaceutical Sciences·Vivek S PurohitSathyamangalam V Balasubramanian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.